SCHEMBL2838581

SCHEMBL2838581

COc1cc([N+](=O)[O-])cc(C=O)c1OC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.69
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 2/20 0.54
MAPT P10636 2/20 0.54
CYP3A4 P08684 1/20 0.54
ALOX15 P16050 1/20 0.54
PRKDC P78527 1/20 0.54
HSD17B10 Q99714 1/20 0.54
PTGS2 P35354 2/20 0.51
HTT P42858 2/20 0.47
KRAS P01116 2/20 0.44
TDP1 Q9NUW8 3/20 0.43
LMNA P02545 2/20 0.43
NTSR1 P30989 1/20 0.43
TSHR P16473 1/20 0.43
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42
TUBA1B P68363 1/20 0.42
TUBA4A P68366 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27773237 0.89 ERN1 (0.64) ERN1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL6313062 0.84 PTGS2 (0.62) ERN1ALDH1A1MAPTCYP3A4PTGS2
SCHEMBL15299073 0.83 ERN1 (0.56) ERN1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL31454148 0.83 ERN1 (0.56) ERN1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL8164727 0.82 ERN1 (0.55) ERN1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL10641812 0.82 ERN1 (0.68) ERN1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL766081 0.82 ERN1 (1.00) ERN1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL1530203 0.82 ERN1 (0.55) ERN1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL29672629 0.82 ERN1 (1.00) ERN1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL29953284 0.82 ERN1 (0.59) ERN1ALDH1A1KDM4EMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106415244-B Reactive marker compounds and uses thereof 中央研究院 2020-04-24 CN disclosed
US-10590116-B2 3-indolyl furanoids as inhibitors of matrix metalloproteinase-9 for prevention of gastric ulcer and other inflammatory diseases COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2020-03-17 US disclosed
US-10119972-B2 Reactive labelling compounds and uses thereof ACADEMIA SINICA (TW) 2018-11-06 US disclosed
US-20180011104-A1 REACTIVE LABELLING COMPOUNDS AND USES THEREOF ACADEMIA SINICA (TW) 2018-01-11 US disclosed
US-9759726-B2 Reactive labelling compounds and uses thereof ACADEMIA SINICA (TW) 2017-09-12 US disclosed
EP-3129767-A1 REACTIVE LABELLING COMPOUNDS AND USES THEREOF Academia Sinica (TW) 2017-02-15 EP disclosed
CN-106415244-A Reactive marker compounds and uses thereof 中央研究院 2017-02-15 CN disclosed
WO-2015148915-A9 REACTIVE LABELLING COMPOUNDS AND USES THEREOF ACADEMIA SINICA (TW) 2016-12-22 WO disclosed
US-20150309041-A1 REACTIVE LABELLING COMPOUNDS AND USES THEREOF ACADEMIA SINICA (TW) 2015-10-29 US disclosed
WO-2015148915-A1 REACTIVE LABELLING COMPOUNDS AND USES THEREOF ACADEMIA SINICA (TW) 2015-10-01 WO disclosed
CN-101248064-A Nitrocatechol derivatives as COMT inhibitors PORTELA & CA SA (PT) 2008-08-20 CN disclosed
CN-1437587-A Benzoxazepinones and their use as squalene synthetase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-08-20 CN disclosed
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
CN-1073430-A Benzanilide derivatives GLAXO GROUP LTD (GB) 1993-06-23 CN disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150309041-A1 REACTIVE LABELLING COMPOUNDS AND USES THEREOF MPI, AADAC, PAICS ERN1 3327/4885ALDH1A1 364/4885KDM4E 4416/4885
US-20180011104-A1 REACTIVE LABELLING COMPOUNDS AND USES THEREOF MPI, AADAC, PAICS ERN1 3264/4885ALDH1A1 273/4885KDM4E 4318/4885
US-10590116-B2 3-indolyl furanoids as inhibitors of matrix metalloproteinase-9 for prevention of gastric ulcer and other inflammatory diseases MMP9, MMP1, TIMP3 ERN1 2946/4885ALDH1A1 310/4885KDM4E 1355/4885
US-10119972-B2 Reactive labelling compounds and uses thereof MPI, AADAC, PAICS ERN1 3264/4885ALDH1A1 273/4885KDM4E 4318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.